Paintraju (Tramadol Hydrochloride)
Tramadol Hydrochloride 50mg
Injections · Prescription medication
Genewon Science Co., Ltd.
MFDS item code 201900729 · Notified 2019.01.30
This product's status changed to Approval withdrawn on 2023.10.04. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Relief of pain after diagnostic procedures or surgery and moderate to severe acute and chronic pain (such as cancer pain)
This medication is used to relieve severe and moderate acute chronic pain, especially pain caused by various types of cancer, as well as pain occurring after diagnosis and surgery.
The dose of this medicine should be adjusted according to the intensity of the patient's pain and clinical response. In general, use the lowest dose that relieves the pain. After administering 50-100mg of tramadol hydrochloride intravenously or intramuscularly as a single dose, repeat the injection every 4-5 hours as needed. A maximum of 400mg may be administered per day. No dose adjustment is necessary in patients 75 years of age or younger without clinically confirmed hepatic or renal impairment. In patients over 75 years of age, excretion of this medicine may be delayed; therefore, adjust the dosing interval as needed. In patients with renal or hepatic impairment, excretion of this medicine may be delayed; therefore, consider extending the dosing interval in these patients.
This medication may cause seizures if administered in excess of the recommended dose; therefore, it is essential to adhere to the prescribed dosage. Additionally, it should be used cautiously in patients with a risk of seizures or those with epilepsy, and it is important to administer it only when necessary. Prolonged use may lead to psychological and physical dependence, so it should only be used for a short period under strict supervision in patients at risk of drug abuse. Caution should be taken to avoid co-administration with alcohol or central nervous system depressants, as this may lead to severe drowsiness, respiratory depression, coma, or death. Particularly, patients who metabolize this drug rapidly due to genetic factors may have increased blood concentrations of active metabolites, heightening the risk of respiratory depression; therefore, dosage adjustments and monitoring are necessary. This medication should not be administered to children under 12 years old or to adolescents under 18 years old who have undergone tonsillectomy or adenoidectomy, and usage should be avoided in this age group when there is a high risk of respiratory depression. Injectable ampoules may contain glass fragments when the container is cut; therefore, special care should be taken when administering to children or the elderly. This drug should not be used in certain patient populations, such as those with acute alcohol intoxication, severe respiratory depression, head injuries, those taking MAO inhibitors, those with severe renal or hepatic impairment, pregnant or breastfeeding women, and those with certain allergic histories. Patients taking morphine, those with liver dysfunction, alcohol users, and those with a history of seizures should be administered this medication with caution, and dosage adjustments and close monitoring may be necessary. During treatment, symptoms such as drowsiness, dizziness, or nausea may occur, so it is advisable to avoid driving or operating dangerous machines. Additionally, prolonged use of this medication may lead to tolerance, necessitating increased dosages, and sudden discontinuation may trigger withdrawal symptoms, so dosage should be gradually reduced. In cases of overdose, severe respiratory depression and seizures may occur, so it is crucial to inform medical personnel immediately for appropriate emergency measures, and an antidote may be required. This medication may interact with various drugs; thus, if other medications are being taken, consultation with healthcare providers is essential before use. Pregnant or breastfeeding women should not use this medication, as serious side effects may occur in the infant, particularly while breastfeeding. In elderly patients, blood concentrations may increase, so the dosage must be restricted, and those over 75 years old should not exceed 300mg per day.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to avoid contact with air and is best kept at room temperature between 1°C and 30°C. Storing it this way helps maintain the effectiveness of the drug.
A clear, colorless, and odorless liquid in a colorless and transparent ampoule.
1mL/ampoule x 50
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Tramadol Hydrochloride 50mg
Injections · Prescription medication
Genewon Science Co., Ltd.
Tramadol Hydrochloride 50mg
Prescription medication
(Yuhan Corporation)

Tramadol Hydrochloride 50mg
Hard capsule · Prescription medication
Yuhan Corporation
Tramadol Hydrochloride 50mg
Injections · Prescription medication
Hanol BioPharma Co., Ltd.
Tramadol Hydrochloride 50mg
Prescription medication
Il Sung IS Co., Ltd.
Tramadol Hydrochloride 100mg
Prescription medication
Il Sung IS Co., Ltd.
Tramadol Hydrochloride 50mg
Prescription medication
Ilseong IS Co., Ltd.
Tramadol Hydrochloride 50mg
Injections · Prescription medication
Donggwang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.